OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract RF7-06: Primary results of Ambre, a randomized phase 3comparing mono-chemotherapy (ct) vs abemaciclib + endocrine therapy (et) in hr+/her2- advanced breast cancer (abc) with high visceral tumor burden

HTML

Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
DOI: 10.1158/1557-3265.sabcs25-rf7-06
Authors: V. Dieras, F. C. Bidard, L. Roca, J. Pierga, T. Bachelot, I. Desmoulins, C. Jouannaud, X. Durando, C. Delbado, S. Lavau-Denes, F. Minne, A. C. Hardy-Bessard, K. Bourcier, O. Derbel, J. Grenier, F. Clatot, S. Renault, J. Lemonnier, C. Vissac-Sabatier, J. Péron, G. Freyer
Institutions: Centre Eugène Marquis, Institut Curie, Institut de Recherche en Cancérologie de Montpellier, Centre Léon Bérard, Centre Georges François Leclerc, Institut Jean Godinot, Centre Jean Perrin, Groupe Hospitalier Diaconesses Croix Saint-Simon, Centre Hospitalier Universitaire de Limoges, Centre Hospitalier de la Côte Basque, Centre Hospitalier De Pau, Hôpital Privé Jean Mermo, Institut Sainte Catherine, Centre Henri Becquerel, UniCancer Group, Hospices Civils de Lyon, Hôpital Lyon Sud, Centre Hospitalier Universitaire de Saint-Étienne
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7129588958
Cites:
Cited by: 1
Related to:
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms